BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic ...

SOPHiA GENETICS SA (NASDAQ:SOPH ... new applications such as MSK-ACCESS and MSK-IMPACT powered with SOPHiA DDM. 2024 also ...

"We continued driving widespread adoption of SOPHiA DDM™ in 2024, achieving a record number of analyses, major new customers wins, and healthy volume growth during the year, despite BioPharma ...

SOPHiA GENETICS SA is a healthcare technology company ... It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex ...

"With SOPHiA DDM™, we have been able to confidently identify genetic rearrangements that provide critical insights into the complexity of cancer," said Dr. Jessica Van Ziffle, Associate ...

Welcome to the SOPHiA GENETICS fourth quarter and full year 2024 ... such as MSK-ACCESS and MSK-IMPACT powered with SOPHiA DDM. 2024 also presented challenges. BioPharma budgets tightened across ...